Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Camurus’ Interim Report Second Quarter 2023

“Outstanding second quarter with strong revenue growth, record result, FDA approval and positive phase 3 results” Second quarter summary April - June · Total revenues amounted to SEK 674 (227) million, an increase of 197% (185% at CER[1]), whereof product sales were SEK 305 (225) million, an increase of 36% (32% at CER[1]) · Compared to previous quarter, product sales increased 8% · Operating result was SEK 376 (7) million, an increase of SEK 369 million · Cash position at the end of the quarter was SEK 654 (428) million, an increase of SEK 226 million (53%) · Number

Inside information: President & CEO Jari Rosendal will leave his position – Kemira Board initiates the search for his successor

Kemira Oyj, INSIDE INFORMATION, July 18, 2023 at 8.00 am (EEST)Inside Information: President & CEO Jari Rosendal will leave his position – Kemira Board initiates the search for his successor Kemira’s Board of Directors and President & CEO Jari Rosendal have agreed that Jari Rosendal will leave his position as the President & CEO latest during 2024. Kemira’s Board has decided to initiate the search for his successor. Jari Rosendal has been Kemira’s President & CEO since 2014. He is currently on sick leave. ”The succession planning for the CEO role is a continuous and long term

Nel ASA: Second quarter 2023 financial results

(July 18 - 2023, Oslo, Norway) Nel ASA (Nel, OSE:NEL) reported record-high quarterly revenues of NOK 475 million in the second quarter of 2023, up 159% from NOK 183 million in the same quarter of 2022. Order intake was NOK 428 million, up 81% year-on-year, positively impacted by the large fueling contract for 16 stations to be deployed in the US. At the end of the second quarter, the order backlog was at NOK 2 964 million, up 106% from Q2 2022. The cash balance was NOK 4 122 million at quarter end. Quarterly highlights · Nel ASA (Nel) reported revenue and income in the second

Atea Q2 2023 financial report and presentation

Atea reported strong revenue growth, higher operating profit and solid cash flow from operations in Q2 2023. · Strong revenue growth:  Group revenue in Q2 2023 increased by 17% to NOK 8,870 million. Organic revenue growth in constant currency was 8%. Growth was spread across all lines of business. Hardware revenue grew by 15%, software revenue grew by 17% and services revenue grew by 21%.  · Higher operating profit:  Based on strong sales performance, Atea’s operating profit (EBIT) grew to a record high NOK 291 million for the second quarter, up from NOK 281 last year. EBIT in Q2

INTERIM REPORT JANUARY - JUNE 2023

Good performance in the gardening season  Second quarter 2023 · Net sales increased by 7% to SEK 16,976m (15,792). Organic sales were relatively unchanged and changes in exchange rates contributed with 7%. · Operating income was SEK 2,101m (2,065) and the operating margin was 12.4% (13.1). Excluding items affecting comparability, the operating income amounted to SEK 2,313m (2,075) and the operating margin was 13.6% (13.1). · Items affecting comparability amounted to SEK -212m (-10), and was related to the acceleration of the strategic transformation, announced in October 2022.

Interim Report January-June 2023

Strong organic growth in a mixed market Second quarter 2023 – Net sales increased by 15.0 percent to SEK 6,869 million (5,975) – Organic growth adjusted for calendar effects was 10.8 percent (7.5) – EBITA, excl. items affecting comparability, was SEK 421 million (451) – EBITA margin, excl. items affecting comparability, was 6.1 percent (7.6) – EBITA totalled SEK 398 million (432) – EBITA margin was 5.8 percent (7.2) – EBIT (operating profit) amounted to SEK 363 million (335) – Basic earnings per share: SEK 1.77 (1.53) January–June 2023 – Net sales increased

Tele2 interim report second quarter 2023

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces its consolidated results for the second quarter 2023.Highlights · End-user service revenue of SEK 5.3 billion increased by 4% organically compared to Q2 2022 due to strong performance in the Baltics and Sweden B2B. Total revenue of SEK 7.2 billion increased by 3% organically compared to Q2 2022. · Underlying EBITDAaL of SEK 2.5 billion remained unchanged organically compared to Q2 2022 as end-user service revenue growth and cost savings related to the Business Transformation Program were offset

SEB’s second quarter 2023 results

SEB’s operating profit for the second quarter 2023 amounted to SEK 12.1bn, with a return on equity of 18.8 per cent, a CET1 capital ratio of 19.3 per cent, and a capital management buffer of 450 basis points.“We report a strong result for the second quarter, driven by our corporate business. We saw sound activity among our large corporate customers, reflected in growing lending and deposit volumes and a pick-up in capital markets activity,” says Johan Torgeby, SEB’s President and CEO. Operating profit increased by 4 per cent in the second quarter compared to the previous quarter. Both

Robert Hafredal appointed CIO at Husqvarna Group

Robert Hafredal is appointed Husqvarna Group’s new EVP Global Information Services and Group CIO, effective August 1, 2023.Robert has held the position as acting EVP Global Information Services since December 2022. “I am proud to pass on responsibility for the future development of Global Information Services into Robert’s capable hands and pleased to welcome him to the Group Management Team. With his leadership, broad experience, and dedication he will further strengthen our IT work that truly is the backbone of all our operations.” Says Pavel Hajman, CEO at Husqvarna Group. Since

Swedbank’s Interim report for the second quarter 2023

Swedbank´s President and CEO Jens Henriksson comments: ”Swedbank stands strong”.· Profit was strengthened – higher income and lower expenses · Net interest income rose due to higher deposit margins · Lower credit impairments and solid credit quality · Stronger liquidity and high activity in funding markets · Strong capitalisation – lower buffer due to increased countercyclical requirement · Reorganisation to strengthen corporate business     Contact: Annie Ho (annie.ho@swedbank.com), Head of Investor Relations, +46 70 343 7815  Unni Jerndal (unni.

TOMRA: Mandatory notification of trade

Hege Skyrseth, board member and primary insider (PDMR) of TOMRA Systems ASA, has today bought 1,613 shares in TOMRA Systems ASA at a price of NOK 155.20 per share. After the transaction Hege Skyrseth holds 4,673 shares in TOMRA Systems ASA. Further disclosure details can be found in the attached form. Asker, 17 July 2023 TOMRA Systems ASA For further information, please contact: Daniel Sundahl, Head of Investor Relations, Tel: +47 91 36 18 99 This information is subject to the disclosure requirements in Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities

National Housing Company Launches "Sadayem" Suburb, the Innovative Integrated Living Project in Jeddah

Jeddah, July 17[th], 2023: The National Housing Company (NHC) launched its latest uber luxury housing project, the “Sadayem” Suburb, in North Obhur in Jeddah. The launch ceremony, organized under the patronage of H.R.H. Prince Badr bin Sultan bin Abdulaziz, Deputy Governor of Makkah Region, the Suburb was officially inaugurated by H.H. Prince Saud bin Abdullah bin Jalawi, Governor of Jeddah. Also present on the occasion were H.E. Abdullah AlBudair, Vice Minister of Municipal and Rural Affairs and Housing, and Mr. Yazid bin Ibrahim Al-Nafisa, Deputy Executive President of the National Housing

Acquisition of own shares / primary insider trades

On 17 July 2023, DNB acquired a total of 142 399 shares in Gjensidige Forsikring ASA ("Gjensidige" or the "Company", OSE:GJF, LEI 5967007LIEEXZX6FAO47, ISIN NO0010582521) on behalf of the Company. 114 325 shares have been sold to employees at a price of NOK 152.1435 per share as part of Gjensidige’s share savings scheme for 2023. For a description of the share savings scheme, see the stock exchange release dated 19 December 2022. Acquisition of shares under the share savings scheme for the second quarter 2023 is now complete. Primary insiders in Gjensidige have on 17 July 2023

Nordea Bank Abp: Repurchase of own shares on 17.07.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares17.07.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 17.07.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |39,355 |10.25 |403,376.94

AegirBio AB has received National Institutes of Health (NIH) programmatic approval for an accessibility project

AegirBio AB has received National Institutes of Health (NIH) programmatic approval for an accessibility project to be funded under the NIH/NIBIB’s Rapid Acceleration of Diagnostics (RADx) initiative. In the first phase of the project, the company can receive up to approximately USD 1 million in milestone based payments with the potential for follow on funding if key feasibility milestones are met. Funding is dependent on reaching the milestones.The company had applied in response to a call for COVID-19 home tests accessible to people with disabilities

Beyfortus approved in US for infant RSV prevention

17 July 2023 Beyfortus approved in the US for the prevention of RSVlower respiratory tract disease in infants First preventive option specifically designed to protectthe broad infant population through its first RSV season Across all clinical endpoints, a single dose of Beyfortus delivered consistent and sustained efficacy against RSV disease vs placebo AstraZeneca and Sanofi's Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their

Transaction in Own Shares

FIDELITY JAPAN TRUST PLC TRANSACTION IN OWN SHARES The Board of Fidelity Japan Trust PLC ("the Company") announces that on 17 July 2023 the Company bought into Treasury 40,000 of its own shares at a price of 170.3750 pence per share.  The Company's issued ordinary share capital is 136,161,695 of which 7,127,636 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is now 129,034,059. The above figure (129,034,059) may be used by shareholders as the denominator for the calculations by which they will determine

Nel ASA: Receives purchase order for 40 MW electrolyser equipment from Bondalti

(July 17, 2023 - Oslo, Norway) Nel Hydrogen Electrolyser AS, a subsidiary of Nel ASA (Nel, OSE:NEL), has signed a contract for 40 MW of alkaline electrolyser equipment for about EUR 11 million with Bondalti for its first phase of the H2 Enable project in Estarreja, Portugal. "We continue to experience good momentum for our electrolysers, and we are happy to partner with a quality company such as Bondalti, an exciting client committed to decarbonisation”, says Nel’s CEO, Håkon Volldal. Bondalti is the largest company in the Portuguese chemical industry. The electrolyser plant, which is

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 17 July 2023 the Company bought 82,930 of its own shares for cancellation at a price of 208.226 pence per share.  The Company's issued ordinary share capital is 567,026,571 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 481,397,023. The above figure (481,397,023) may be used by shareholders as the denominator for the

DanCann Pharma A/S Successfully Receives First Tranche from the 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 17 July 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce, that the Company based on an authorization from the general meeting, resolved to issue loan notes to an aggregate amount of DKK 18,900,000, and 8,190,000 warrants to Nordic Growth Opportunities 2 (the “Investor” or “NGO2”) in connection with the Company’s receipt of first tranche of DKK 6,600,000 of the total loan from the Investor pursuant to the financing agreement entered into with the Investor as described in a

Preliminary 2023 SREP decision

The Swedish Financial Supervisory Authority has informed SEB of its preliminary decision regarding the 2023 Supervisory Review and Evaluation Process (SREP).According to the preliminary decision, SEB’s Pillar 2 requirement (P2R) would increase by around 0.2 percentage point for CET1 capital. The increase is mainly driven by a temporary add-on for the ongoing review of IRB-models. At the same time, the risk-weight floor for commercial real estate is transferred from P2R to Pillar 1, thereby increasing the risk exposure amount (REA).Furthermore, the REA-based Pillar 2 guidance (P2G) would

SEB completes latest share buyback programme and initiates new programme

SEB has completed its latest share buyback programme, under which SEK 1.25 billion of Class A shares have been repurchased. The Board of Directors has resolved to utilise the authorisation granted by the 4 April 2023 Annual General Meeting to initiate a new SEK 1.25 billion buyback programme of Class A shares running until 23 October 2023. On 25 April 2023, SEB announced a SEK 1.25 billion share buyback programme for capital management purposes. The repurchases of shares began on 27 April 2023 and ended on 14 July 2023. During this period, SEB repurchased 10,660,063 of its own Class A

There are no items matching the current filter
There are no more items matching the current filter
Back to top